| p53 status determines the role of autophagy in pancreatic tumour development MT Rosenfeldt, J O’Prey, JP Morton, C Nixon, G MacKay, A Mrowinska, ... Nature 504 (7479), 296-300, 2013 | 723 | 2013 |
| Mannose impairs tumour growth and enhances chemotherapy PS Gonzalez, J O’Prey, S Cardaci, VJA Barthet, J Sakamaki, F Beaumatin, ... Nature 563 (7733), 719-723, 2018 | 340 | 2018 |
| The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer AK Najumudeen, F Ceteci, SK Fey, G Hamm, RT Steven, H Hall, ... Nature genetics 53 (1), 16-26, 2021 | 135 | 2021 |
| Targeting mTOR dependency in pancreatic cancer DC Morran, J Wu, NB Jamieson, A Mrowinska, G Kalna, SA Karim, ... Gut 63 (9), 1481-1489, 2014 | 134 | 2014 |
| A RhoA-FRET biosensor mouse for intravital imaging in normal tissue homeostasis and disease contexts M Nobis, D Herrmann, SC Warren, S Kadir, W Leung, M Killen, ... Cell reports 21 (1), 274-288, 2017 | 94 | 2017 |
| Intravital FRAP imaging using an E-cadherin-GFP mouse reveals disease-and drug-dependent dynamic regulation of cell-cell junctions in live tissue Z Erami, D Herrmann, SC Warren, M Nobis, EJ McGhee, MC Lucas, ... Cell reports 14 (1), 152-167, 2016 | 68 | 2016 |
| Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer R Patel, EA Brzezinska, P Repiscak, I Ahmad, E Mui, M Gao, A Blomme, ... Cancer Research 80 (3), 576-590, 2020 | 35 | 2020 |
| Australian Pancreatic Cancer Genome Initiative (APGI), Oien KA, McKay CJ, Carter CR, Gillen G, Champion S, Pimlott SL, Anderson KI DC Morran, JNB WJ, A Mrowinska, G Kalna, SA Karim, AY Au, CJ Scarlett, ... Evans TR, Grimmond SM, Biankin AV, Sansom OJ, Morton JP. Targeting mTOR …, 2014 | 15 | 2014 |
| 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy G Malviya, R Patel, M Salji, RS Martinez, P Repiscak, E Mui, S Champion, ... EJNMMI research 10, 1-10, 2020 | 12 | 2020 |
| Human-correlated genetic HCC models identify combination therapy for precision medicine M Müller, S May, H Hall, TJ Kendall, L McGarry, L Blukacz, S Nuciforo, ... | 3 | 2022 |
| Abstract PR07: A biosensor mouse to predict the dissociation and spread of pancreatic cancer D Herrmann, Z Erami, S Warren, M Nobis, A Magenau, M Lucas, ... Cancer Research 77 (2_Supplement), PR07-PR07, 2017 | | 2017 |
| 18F-FACBC PET/MR Imaging as a Tool to Monitor Tumour Response to Androgen Deprivation Therapy in Prostate Cancer G Malviya, R Patel, E Mui, S Champion, A Mrowinska, E Johnson, ... 5th Symposium 42 (11), 29, 0 | | |
| The Role of Autophagy in Pancreatic Cancer Is Determined by p53 Status MT Rosenfeldt, J O’Prey, JP Morton, C Nixon, G MacKay, A Mrowinska | | |
